Personalis, Inc. to Present at the American Association for Cancer Research (AACR) Annual Meeting 2019

On March 31, 2019 Personalis, Inc., a leader in advanced genomics for cancer, reported that the company will present one oral presentation and five posters at the American Association for Cancer Research (AACR) (Free AACR Whitepaper) Annual Meeting being held this year in Atlanta, GA from March 31 – April 3, 2019 (Press release, Personalis, MAR 31, 2019, View Source [SID1234534789]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Personalis presentations will highlight how fundamental oncology research informs the ongoing evolution of our leading immunogenomics analysis platform. The presentations will also detail the alignment between our genomics solutions and AACR (Free AACR Whitepaper)’s 2019 theme: Integrative Cancer Science • Global Impact • Individualized Patient Care.

Following is a list of abstracts that will be presented at the meeting.

Presentation # Title & Presenter Day & Time Location
905 (Oral Presentation)
Comprehensive immunogenomic profiling of anti-PD-1 treated melanoma patients reveals subject-specific tumor escape mechanisms

March 31
3:05 pm-3:20 pm Room B206
2512 / 8
A comprehensive genomics platform for precision immunotherapy: Simultaneously characterizing the tumor and tumor microenvironment from a single FFPE sample

April 1
1-5pm Poster section 33
T-cell receptor repertoire profiling using an augmented transcriptome

April 2
8 am-12 pm Poster section 31
3788 / 5
Sensitive detection of oncoviruses integrated into a comprehensive tumor immuno-genomics platform

April 2
1 pm-5 pm Poster section 8
4536 / 9
Applying Immuno-Peptidomics and Machine Learning to Improve Neoantigen Prediction for Therapeutic and Diagnostic Use

April 3
8 am-12 pm Poster section 2
4695 / 8
Development and Validation of an Accurate Exome-Scale cfDNA Detection Platform

April 3
8 am-12 pm